Welsh, Carson, Anderson & Stowe Names Gregory Lau as a General Partner and Member of the Firm's Fundraising and Investor Relations Team

Abzena has extensive experience in cGMP and non-GMP production for recombinant proteins, antibodies and conjugates products for preclinical and clinical materials. Abzena’s expertise in employing single-use technology allows for rapid turnaround times and cost effective solutions.The post Manufacturing & Cell Line Development at Abzena appeared first on abzena.